LumeNXT, Inc recently announced the appointment of Marc Beer as the firm’s Board Chairman. LumeNXT, Inc., is a private for-profit organization that deals with the creation of proprietary surgical illumination products that are used in minimally invasive surgeries. Marc Beer is bringing along with him over two decades worth of experience in pharmaceuticals, biotechnology and device development and commercialization among others.
Marc Beer in a statement regarding the appointment said that he is proud and honored to join the LumeNXT family. LumeNXT comprises of a team of dedicated and accomplished staff who have worked tirelessly to develop innovative surgical solutions through the development of proprietary technology that has enhanced minimally invasive surgery which is considered to be the safest and most precise mode of operation. Beer added that he believes that LumeNXT is destined for greatness as more surgeries are going to be performed using the firm’s technology.
Targeted illumination technology that the firm boasts of has helped enhanced visualization, precision and also flexibility during surgeries as compared to the traditional surgical methods. The LumeNXT platform utilizes the heat reduction mechanism that helps improve surgical accuracy and increases safety through enhanced visualization among other things.
In another statement concerning the appointment, LumeNXT Co-Founder Mr. Paul Rhyne said that the firm is pleased to have Marc Beer as its Board Chairman. Beer is a renowned serial entrepreneur who has successfully helped established multiple startup companies. His vast entrepreneurial experience will go a long way in assisting LumeNXT to reach greater horizons in the healthcare industry said, Rhyne.
Marc Beer current undertakings including serving as the CEO and Chairman of Renovia, Inc, a company he co-founded in 2016 to help in the treatment and diagnosis of pelvic floor disorders that is affecting the lives of millions of women worldwide. Beer before founding Renovia served in various multinational healthcare companies in senior executive roles. Among the companies that Beer has served include Minerva Neurosciences, Inc., where he served as the firms founding Chairman. Minerva Neurosciences is a biopharmaceutical firm that deals with the creation of a range of products that are aimed at treating central nervous system diseases as well as diseases such as schizophrenia, insomnia, and depressive disorders among others. Other firms that Beer has served in senior capacities include Good Start Genetics, Inc., where he served as a board chairman, ViaCell where he served as the founder and CEO, Erytech Pharma where he served at the Board of Directors and Genzyme among others. Marc Beer has an excellent academic background and holds a Bachelors of Science degree from the prestigious Miami University. Learn more: https://www.benzinga.com/pressreleases/18/08/r12237847/osf-ventures-invests-in-company-developing-solutions-for-pelvic-floor-